EN 16185-2
Railway Brake Disc Acoustic Emissions Testing
This test method evaluates the acoustic emissions generated by railway brake disc and pad/block interactions under controlled conditions. It measures noise characteristics produced during braking events to assess the potential for noise disturbance in railway operations. The test is critical for railway operators and brake component manufacturers seeking to comply with noise regulations and ensure passenger comfort. Accreditation is essential to provide independent, standardized verification that brake systems meet acoustic performance requirements across European rail networks.
What it measures
- Sound pressure levels during brake pad-disc contact
- Frequency spectrum of brake-induced noise
- Peak noise emissions under defined braking scenarios
- Acoustic performance consistency across brake cycles
- Compliance with European noise limits
🇩🇪
DIN EN 16185-1
🇬🇧
BS EN 16185-1
🇫🇷
NF EN 16185-1
🇮🇹
UNI EN 16185-1
🇪🇸
UNE EN 16185-1
🇳🇱
NEN EN 16185-1
🇩🇪
DIN EN 16834
🇬🇧
BS EN 16834
🇫🇷
NF EN 16834
🇮🇹
UNI EN 16834
🇪🇸
UNE EN 16834
🇳🇱
NEN EN 16834
1,273
Accredited labs
15
Countries
Showing 1,176–1,200 of 1,273 labs
angeborener Chromosomensatz
Molybdän-Cofaktor Defizienz
(MOCS1, MOCS2)
Fragiles X-Syndrom: FMR1
Spinocerebellare Ataxie (SCA)
+ 3 more
Thrombozytenaggregation
Born
Verschlußzeit Kollagen/ADP
Verschlußzeit Kollagen/Adrenalin
6-Methyl-Mercaptopurinnukleotide
+ 3 more
Thrombozytenaggregation
Born
Verschlußzeit Kollagen/ADP
Verschlußzeit Kollagen/Adrenalin
6-Methyl-Mercaptopurinnukleotide
+ 3 more
angeborener Chromosomensatz
Molybdän-Cofaktor Defizienz
(MOCS1, MOCS2)
Fragiles X-Syndrom: FMR1
Spinocerebellare Ataxie (SCA)
+ 3 more
alpha-Aminobuttersäure
Mianserin
Arginin
Asparagin
Asparaginsäure
+ 3 more
Candida spp.-Antikörper
Cardiolipin-Antikörper
Meningitiserreger-Ag (E. coli
Staphylococcus aureus
Treponema pallidum-Antikörper
+ 3 more
Granulozytäre Antikörper
(Screening und Differenzierung)
HLA spezifische Antikörper
B-Streptokokken (Screening)
Ektoparasiten (Differenzierung)
+ 3 more
Anti-Thyreoglobulin-Antikörper
[Anti-TG]
Anti-Thyreoperoxidase Antikörper
[Anti-TPO]
Anti-TSH-Rezeptor Antikörper
+ 3 more
angeborener Chromosomensatz
Silver-Russell-Syndrom:
H19, KCNQ1OT1
MEST
Deletion; Angelman-Syndrom
+ 3 more
5-Hydroxyindolessigsäure
Amitriptylin/Nortriptylin
Cyclosporin A
Gesamt-Itraconazol
Metanephrine, Normetanephrine
+ 3 more
IEC 60061-1
IEC 60061-2
IEC 60238
IEC 61184
IEC 60400
+ 3 more
(HSG 248) – 2021
ASB/10 based on HSG 248
(PCM) based on HSG 248
ASB/6 based on HSG 248
BS EN ISO 14644-1:2015
+ 3 more
Myopathie, Nemaline (TyP1, 3-10:
ASTM E 23-18
ASTM D 1322
Toxizität UGT1A1-Gen rs3064744, rs414832
DIN EN 1789
+ 3 more
5 a 18 mm/s (Valor pico) (frecuencias en
5 a 12 mm/s (RMS) (frecuencias entre 8 H
VWR International
Active
TEMPERATURE
parameters and ranges)
indicators or recorders
WEIGHING INSTRUMENTS
Vectoflow
Active
am Standort Vectoflow Windtunnel A, Frie
Strömungsgeschwindigkeit
von Gasen 15 m/s bis
> 38 m/s
fem
Active
DIN EN ISO 1463
DIN EN ISO 3497
DIN EN 14518
DIN EN ISO 18452
IEC 62642-3
+ 3 more
Blutbild, kleines (Erythrozyten, Leukozy
Erythrozyten
Leukozyten
Retikulozyten
Thrombozyten
+ 3 more
Vintec Laboratories
Active
(HSG 248) – 2021
(PCM) based on HSG 248
P052 based on HSG 248
Vistec Electron Beam
Active
− Permanentes Laboratorium
Positionen und Abstände
gleichgerichteter Kanten
positionen von Strukturen
(Hartschichtmasken)
+ 3 more
No matching labs found.